Dr. Amaka Eneanya spoke recently on NPR’s Weekend Edition Saturday about the Trump Administration’s strategy for “Advancing American Kidney Health.” Dr. Eneanya is an assistant professor of medicine at the Hospital of the University of Pennsylvania, a practicing nephrologist, and an ASN member (@AmakaEMD).
In the first major transformation in kidney care in almost 50 years, the Trump Administration today announced the Advancing the American Kidney Health initiative. The comprehensive kidney health strategy will bring sweeping changes to care for people with kidney diseases, including more choices for dialysis modalities, greater access to transplantation, and concerted support for development of innovative therapies, including artificial kidneys.
On the Advancing American Kidney Health Initiative
"The American Society of Nephrology (ASN) applauds the bold vision unveiled today by President Donald J. Trump and by Department of Health and Human Services (HHS) Secretary Alex Azar, II, in the Advancing American Kidney Health initiative. Before an audience of more than 500 individuals with kidney diseases, nephrologists, and other kidney community advocates, President Trump signed an Executive Order launching the initiative.
In today’s session on the “Future of Value-Based Care,” Tom Duvall, co-lead on the ESRD Seamless Care Organization (ESCO) models at the CMS Innovation Center, updated Kidney Week attendees on the status of the ongoing ESCO models that qualify as Advanced Alternative Payment Models (APMs) under the Quality Payment Program. Duvall asked for feedback on how the models are currently operating and for input on how to accomplish various goals as CMS considers the next iteration of ESCOs after the current ones are completed in 2020. In particular, Duvall requested Kidney Week participants submit answers to four questions: